Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CARD19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SDF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf94 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B9D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESRRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MRPL55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFKL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALKBH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on